CJC-1295 with DAC (Drug Affinity Complex) is a modified research peptide designed to stimulate and sustain growth hormone (GH) release for extended durations. The DAC modification extends the peptide’s half-life, allowing for more consistent and prolonged action in research studies.
This peptide has been studied for its potential benefits in promoting muscle development, improving fat metabolism, supporting cellular regeneration, and enhancing recovery processes in research models. The prolonged activity provided by the DAC makes it particularly valuable in studies requiring sustained growth hormone stimulation without frequent administration.
Note: CJC-1295 with DAC is intended for research purposes only and is not approved for human use or consumption.
Reviews
There are no reviews yet.